Business
Novavax vaccine 90 per cent effective – PerthNow
Data from its US clinical trial shows this new vaccine is more than 90 per cent effective against COVID-19, and it could be in…
Novavax Inc has reported late-stage data from its US-based clinical trial showing its vaccine is more than 90 per cent effective against COVID-19 across a variety of variants of the virus.
The study of nearly 30,000 volunteers in the United States and Mexico…
Continue Reading
-
Business14 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business18 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Business10 hours agoDicker Data rides the AI trend to double digit growth
-
General23 hours agoDenmark summons US envoy over suspected influence operations in Greenland